NRC Health Reports First YoY Revenue Growth Since 2023, Record TRCV, and Strong Cash Flow in Q1

summarizeSummary

NRC Health announced its first quarter 2026 results, highlighting its first year-over-year revenue growth since 2023, record Total Recurring Contract Value, and increased cash flow from operations, despite a decline in net income.

check_boxKey Events

• First Year-over-Year Revenue Growth Since 2023

  Total revenue for Q1 2026 was $34.8 million, marking a 4% increase from the prior year and the first year-over-year growth since 2023.

• Record Total Recurring Contract Value (TRCV)

  TRCV reached a record $152.1 million, up 13% year-over-year, representing the sixth consecutive quarter of sequential growth.

• Signed Largest Deal in Company History

  The company announced the signing of the largest deal in its 45-year history, validating its strategic direction and value proposition.

• Improved Cash Flow from Operations

  Net cash flow from operating activities increased 8% year-over-year to $7.2 million, with free cash flow rising to $5.4 million.

auto_awesomeAnalysis

NRC Health's first quarter 2026 results present a mixed financial picture but highlight significant operational momentum. While GAAP net income and earnings per share declined year-over-year, the company achieved its first year-over-year revenue growth since 2023 and reported record Total Recurring Contract Value (TRCV), indicating a potential turnaround in its growth trajectory. The CEO's announcement of the largest deal in the company's 45-year history further underscores strong operational execution and future revenue potential. Additionally, improved cash flow from operations provides a solid financial foundation. Investors should monitor if this operational strength translates into sustained profitability in upcoming quarters.